Evidence map›Paper›PMID 36443373›Full record

ArticleScientific reports2022

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease.

Magnus Holmer, Hannes Hagström, Ping Chen, Olof Danielsson, Myriam Aouadi, Mikael Rydén, Per Stål

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Nidogen 2 Overexpression Promotes Hepatosteatosis and Atherosclerosis.International journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Magnus HolmerDivision of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University Hospital, 141 86, Stockholm, Sweden. magnus.holmer@ki.se.
Hannes HagströmDivision of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Ping ChenDepartment of Medicine, Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Olof DanielssonDivision of Pathology, Department of Laboratory Medicine, Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Myriam AouadiDepartment of Medicine, Huddinge, Center for Infectious Medicine (CIM), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Mikael RydénEndocrinology Unit, Department of Medicine, Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Per StålDivision of Liver and Pancreatic Diseases, Department of Upper GI, Huddinge C1-77, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipocyte hypertrophy and expression of adipokines in subcutaneous adipose tissue (SAT) have been linked to steatosis, nonalcoholic steatohepatitis (NASH) and fibrosis in morbidly obese (BMI ≥ 40 kg/m

Indexed as

Non-alcoholic Fatty Liver DiseaseObesity, MorbidAdipocytesAdipokinesBiopsy, Fine-NeedleFibrosisHumansHypertrophyAdipokines

Identifiers

PMID36443373
PMCPMC9705525
OpenAlexW4310117562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.